Scholarly Index
Jeffrey H. Lipton
Princess Margaret Cancer Centre; 17,472 total citations; 663 total publications; best world rank #107
Princess Margaret Cancer Centre
17,472Total citations
663Total publications
58H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Chronic Myeloid Leukemia Treatments | Lifetime | 191 | CA 4 | 99.00 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 417 | CA 14 | 98.83 |
| Eosinophilic Disorders and Syndromes | Lifetime | 199 | CA 5 | 98.34 |
| Acute Lymphoblastic Leukemia research | Lifetime | 543 | CA 15 | 98.04 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 527 | CA 18 | 98.00 |
| Acute Myeloid Leukemia Research | Lifetime | 772 | CA 18 | 97.96 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 550 | CA 6 | 96.21 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 671 | CA 41 | 89.91 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 107 | CA 2 | 98.00 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 243 | CA 5 | 97.21 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 120 | CA 2 | 94.71 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 336 | CA 12 | 94.13 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 534 | CA 12 | 92.31 |
| HER2/EGFR in Cancer Research | 2021-2025 | 986 | CA 15 | 84.56 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 503 | CA 24 | 77.82 |